EAU 2013 - Programme Book - YouMed

Sponsored Sessions
Saturday, 16 March
402 Programme Book
Sponsored Session
18.00 - 19.30 Navigating the new landscape in CRPC
eURO Auditorium - Level S2
Symposium
Chairs: A. Heidenreich, Aachen (DE)
C.N. Sternberg, Rome (IT)
Introduction to symposium
A. Heidenreich, Aachen (DE)
CRPC: The rationale for targeting the androgen receptor
J.A. Schalken, Nijmegen (NL)
New and emerging post-chemotherapy CRPC treatments: Clinical experience
C.N. Sternberg, Rome (IT)
Implications of the evolving pre-chemotherapy landscape
A. Heidenreich, Aachen (DE)
Interactive Q&A discussion session: Optimising patient care in the new CRPC era
N.W. Clarke, Manchester (GB)
Closing summary
C.N. Sternberg, Rome (IT)
Aims and objectives
• To provide the rationale for targeting the androgen receptor in CRPC
• To present clinical experience of new and emerging therapies in patients with CRPC who have received
prior chemotherapy
• To highlight and discuss the implications of emerging treatments for patients with CRPC who have not
received prior chemotherapy
• To discuss the potential impact of new and emerging therapies on the CRPC treatment landscape, patient
pathway and the dynamics of the multidisciplinary team
Sponsored by ASTELLAS